INTEL CORP ⋅ 10-Q ⋅ 7/24 Philip Morris International Inc. ⋅ 10-Q ⋅ 7/24 TEXAS INSTRUMENTS INC ⋅ 10-Q ⋅ 7/24 AMERICAN EXPRESS CO ⋅ 10-Q ⋅ 7/24 NEXTERA ENERGY INC ⋅ 10-Q ⋅ 7/24 CME GROUP INC. ⋅ 10-Q ⋅ 7/24 KINDER MORGAN, INC. ⋅ 10-Q ⋅ 7/24 TE Connectivity plc ⋅ 10-Q ⋅ 7/24 LAS VEGAS SANDS CORP ⋅ 10-Q ⋅ 7/24 HALLIBURTON CO ⋅ 10-Q ⋅ 7/24

INTEL CORP ⋅ 10-Q ⋅ 7/24 Philip Morris International Inc. ⋅ 10-Q ⋅ 7/24 TEXAS INSTRUMENTS INC ⋅ 10-Q ⋅ 7/24 AMERICAN EXPRESS CO ⋅ 10-Q ⋅ 7/24 NEXTERA ENERGY INC ⋅ 10-Q ⋅ 7/24 CME GROUP INC. ⋅ 10-Q ⋅ 7/24 KINDER MORGAN, INC. ⋅ 10-Q ⋅ 7/24 TE Connectivity plc ⋅ 10-Q ⋅ 7/24 LAS VEGAS SANDS CORP ⋅ 10-Q ⋅ 7/24 HALLIBURTON CO ⋅ 10-Q ⋅ 7/24

AbbVie Inc.

Pharmaceutical Preparations | SIC: 2834
Phone: (847) 932-7900

CIK: 0001551152
EIN: 320375147
State Location: IL
State of Inc.: DE

NYSE:ABBV

Form: 4

Filing Date: 02 Jul 2026
Report Date: 30 Jun 2026
Accepted: 02 Jul 2026 03:00 p.m.
Accession Number: 0001997505-26-000008

Act: None
File Number: None
Film Number: None

Documents

Primary Document

Accepted: 02 Jul 2026 03:00 p.m.

0001997505-26-000008-index-headers.html

Last Modified: 02 Jul 2026 03:00 p.m.

0001997505-26-000008-index.html

Last Modified: 02 Jul 2026 03:00 p.m.

0001997505-26-000008.txt

Last Modified: 02 Jul 2026 03:00 p.m.

form4-07022026_050702.xml

Last Modified: 02 Jul 2026 03:00 p.m.